Carol R. Lizak's most recent trade in Jaguar Health Inc was a trade of 5,400 Warrant to Purchase Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 5,400 | 5,400 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 5,400 | 5,400 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 34,240 | 34,240 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 4,280 | 4,297 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 431 | 1,042 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 431 | 431 | - | - | Restricted stock units | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 60 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 60 | 611 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 142,088 | 142,745 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 431 | 862 | - | - | Restricted stock units | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 431 | 657 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 60 | 226 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 60 | 60 | - | - | Restricted stock units | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2022 | 14,294 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 4,513 | 9,028 | - | - | Restricted stock units | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 4,513 | 12,481 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 81,250 | 81,250 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Carol R. Lizak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 40,625 | 40,625 | - | - | Restricted stock units |